Co-Diagnostics secures CE Mark for direct saliva SARS-CoV-2 test

LabPulse.com staff writers
Jun 20, 2021
2020 06 15 18 14 5259 Swab Sample Collection 400

Molecular diagnostics company Co-Diagnostics has secured the CE-IVD Mark for its Logix Smart SARS-CoV-2 direct saliva test.

The test identifies the presence of the RdRp and E genes of SARS-CoV-2 from human saliva samples and eliminates the RNA extraction process, making it less costly and time-consuming, according to the firm.

Latest in Research and Development
Cancer Cell Microenvironment Social
Gilead, Tubulis to collaborate on ADC program
December 3, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Research Money Social
OraSure awarded BARDA contract for Marburg virus disease test
December 2, 2024
Genome Sequence Barcode Social
Oxford Nanopore, UK Biobank to collaborate on epigenetic dataset
November 27, 2024
Related Stories
2021 12 30 00 31 3981 Business Graph Money Stocks 400
Infectious
Co-Diagnostics reports record revenue in 2021
2020 04 14 22 00 7772 Business Men Handshake 400
Mergers & Acquisitions
Co-Diagnostics to buy Idaho Molecular, Advanced Conceptions
2021 01 08 22 21 6464 Sars Co V 2 Rna 400
COVID-19
Co-Diagnostics says its COVID tests effective vs. omicron variant
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Research and Development
Gilead, Tubulis to collaborate on ADC program
By LabPulse.com staff writers
Gilead and biotech firm Tubulis have forged an exclusive option and license agreement to discover and develop an antibody-drug conjugate (ADC) against an undisclosed solid tumor target.
December 3, 2024
Cancer Cell Microenvironment Social
Oncocyte releases data on transplant rejection assay
By LabPulse.com staff writers
Diagnostics developer Oncocyte has announced study data showing that its monitoring assay for kidney transplant rejection significantly reduces the time to diagnosis.
December 4, 2024
Kidneys Closeup Social
OraSure awarded BARDA contract for Marburg virus disease test
By LabPulse.com staff writers
OraSure Technologies was awarded federal funding for the development of a Marburg virus disease rapid antigen test.
December 2, 2024
Research Money Social
Oxford Nanopore, UK Biobank to collaborate on epigenetic dataset
By LabPulse.com staff writers
Oxford Nanopore and the UK Biobank are collaborating on an initiative to create a comprehensive, large-scale epigenetic dataset, with the aim of gaining critical insights into the mechanisms of common diseases.
November 27, 2024
Genome Sequence Barcode Social
Evolutionary medical genomics program launched in Barcelona
By LabPulse.com staff writers
Three Barcelona, Spain-based research institutions launched the first Joint Program on Evolutionary Medical Genomics last week at an inaugural symposium held at the Barcelona Biomedical Research Park.
November 25, 2024
Science Genome Sequence Dna Map Social
Vyriad, Novartis to collaborate on CAR-T cell therapies
By LabPulse.com staff writers
Clinical-stage biotech firm Vyriad has entered into a strategic partnership with Novartis to discover and develop chimeric antigen receptor (CAR) T-cell therapies.
November 22, 2024
T Cell Social
Pattern Bioscience awarded $22.5M BARDA contract
By LabPulse.com staff writers
Diagnostic technology company Pattern Bioscience has been awarded a cost-share contract by BARDA that is potentially worth up to $40 million.
November 21, 2024
Antibiotic Resistant Bacteria Social
Revvity broadens work in newborn testing for NHS England
By LabPulse.com staff writers
Revvity, formerly PerkinElmer, will expand its work with Genomics England to continue the Generation Project.
November 20, 2024
Baby Infant Mom Closeup Social
Large language models tapped for speeding up clinical trial enrollment in U.S.
By Liz Carey
Meanwhile, the FDA envisions integrating more clinical trial activities into local healthcare facilities, roaming mobile research units, and through at-home lab testing kits.
November 19, 2024
Clinical Trial Data Network Social
Brain tumor collaborative offers $500K for practice changing liquid biopsy studies
By LabPulse.com staff writers
The research should be practice-changing.
November 14, 2024
Lab Test Tube Dna Blood Social
FDA fall IVD roundtable avoids LDT questions
By Liz Carey
In addition, CAP LDT webinar offers beginning guide for phase one compliance.
November 12, 2024
Diagnostic Analyzer Lab Pcr Social
Mainz Biomed, Thermo Fisher collaborate on CRC screening test
By LabPulse.com staff writers
Mainz Biomed and Thermo Fisher Scientific will jointly develop and potentially commercialize Mainz Biomed's next-generation colorectal cancer (CRC) screening test.
November 12, 2024
Colorectal Cancer Social
Page 1 of 43
Next Page